Mitochondrial energy metabolism enzyme

Mitochondrial energy metabolism enzymes represent a broad class of proteins responsible for the production of cellular energy through pathways such as the tricarboxylic acid (TCA) cycle, fatty acid beta-oxidation, and oxidative phosphorylation (OXPHOS) via the electron transport chain (ETC) (NIH, 2024; MDPI, 2020). These enzymes, including complexes I-V and various dehydrogenases, are essential for maintaining ATP levels, regulating cellular redox states, and mediating apoptosis (NIH, 2025; AHA, 2024). Dysregulation of these enzymes is a hallmark of numerous pathologies; for instance, cancer cells often exhibit metabolic reprogramming to favor glycolysis or specific mitochondrial pathways for biosynthesis, while neurodegenerative and cardiovascular diseases are frequently associated with mitochondrial enzyme deficiencies and oxidative stress (Northwestern, 2020; NIH, 2022). Therapeutic strategies targeting these enzymes include the use of inhibitors like metformin for Complex I or activators like dichloroacetate for the pyruvate dehydrogenase complex (News-Medical, 2026; Portland Press, 2024). However, because these enzymes are fundamental to the survival of almost all cell types, pharmacological intervention carries significant risks of systemic toxicity, such as lactic acidosis and organ failure (NIH, 2024).

Other names

Mitochondrial metabolic enzymesMitochondrial respiratory chain enzymesOXPHOS enzymesTCA cycle enzymesMitochondrial bioenergetic enzymes

Modulation of mitochondrial bioenergetics through the inhibition or activation of specific enzymes in the electron transport chain (e.g., Complex I inhibition by metformin), the TCA cycle (e.g., IDH2 inhibition by enasidenib), or substrate oxidation pathways (e.g., PDK inhibition by dichloroacetate) to alter ATP production, redox balance, and metabolite availability (News-Medical, 2026; NIH, 2024).